Acid Ceramidase; A Novel Therapeutic Target in Cancer.

Vijayan Y, Lankadasari MB, Harikumar KB (2019).
Current Topics in Medicinal Chemistry     doi: 10.2174/1568026619666190227222930. [Epub ahead of print]

TAMing pancreatic cancer: combat with a double edged sword.

Lankadasari MB, Mukhopadhyay P, Mohammed S, Harikumar KB (2019).
Molecular Cancer     18(1):48.

Examination of the role of sphingosine kinase 2 in a murine model of systemic lupus erythematosus.

Mohammed S, Vineetha NS, James S, Aparna JS, Lankadasari MB, Allegood JC, Li QZ, Spiegel S, Harikumar KB (2019).
FASEB Journal     33(6):7061-7071

Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine.

Lankadasari MB, Aparna JS, Mohammed S, James S, Aoki K, Binu VS, Nair S, Harikumar KB (2018).
Theranostics     8(14): 3824-384

The origin and functions of exosomes in cancer.

Rajagopal C, Harikumar KB (2018).
Frontiers in Oncology.     20;8:66.

Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy.

Rajagopal C, Lankadasari MB, Aranjani JM, Harikumar KB (2018).
Pharmacological Research     130:273-291.

Enhanced expression of histone chaperone APLF associate with breast cancer.

Majumder A, Syed KM, Mukherjee A, Lankadasari MB, Azeez JM, Sreeja S, Harikumar KB, Pillai MR, Dutta D (2018).
Molecular Cancer.     17(1):76.

Sphingosine 1-Phosphate: A novel target for lung disorders.

Mohammed S, Harikumar KB (2017).
Frontiers in Immunology     8:296.

Contact

Rajiv Gandhi Centre for Biotechnology (RGCB),
Thycaud Post, Poojappura,
Thiruvananthapuram - 695 014, Kerala, India
+91-471-2529400 | 2347975 | 2348753
+91-471-2348096
webmaster@rgcb.res.in